Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Spanish Lung Cancer Group"
Count: 26
Selected: 0
NCT IDTitle
NCT04344002LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)
NCT03526900Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis
NCT03496766Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS
NCT03156868Analysis of Soluble Mediators, Cytokines, and Circulating Angiogenic Factors (FACs) as Potential Predictors / Prognostic Factors in Advanced Non-squamous Lung Carcinoma
NCT03081689Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients
NCT02941458Thoracic Tumours Register
NCT00883480Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma
NCT03526887Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC
NCT03293680Pembrolizumab in Elderly Patients With Advanced Lung Cancer
NCT03094286Durvalumab in Solid Tumors
NCT03363139T790M Mutation Testing in Blood by Different Methodologies
NCT02709720Locally Advanced Trial of Tri-weekly Metronomic Oral Vinorelbine and Cisplatin as Induction Therapy and Subsequent Concomitance With Radiation Therapy in Patients With Unresectable Non Small Cell Lung Cancer (NSCLC)
NCT03132493Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient
NCT01513174Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone
NCT01088906Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC
NCT00617656Multicenter, Predictive, Prospective, Phase III, Open, Randomized, Pharmacogenomic Study in Patients With Advanced Lung Carcinoma
NCT00478699Randomized Customized Adjuvant Chemotherapy (GECP-SCAT)
NCT01814163Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab
NCT00446225Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients With Mutations in the TK Domain of EGFR
NCT00503971Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.
NCT01652820Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer
NCT00913705Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer
NCT01562028BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
NCT02183870EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer
NCT00433563Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer
NCT00037713Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG